Venus Remedies Limited uses cookies to improve site functionality, provide you with a better browsing experience, and to enable our partners to advertise to you. Detailed information on the use of cookies on this Site, and how you can decline them, is provided in our Privacy Policy. By using this Site or clicking on "OK", you consent to the use of cookies.
Operations

Operations

Venus's operations are unique because they juxtapose domestic and international operating facilities, augmenting its capabilities to offer its clients an unparalleled value proposition: cutting-edge technology and optimised costs. The company has three manufacturing units, two being in india and another in germany. The quality of the service provided hinges on quality control, in-process control guidelines and staff training.
Pharmaceutical Plant

Operations

Venus's operations are unique because they juxtapose domestic and international operating facilities, augmenting its capabilities to offer its clients an unparalleled value proposition: cutting-edge technology and optimised costs. The company has three manufacturing units, two being in india and another in germany. The quality of the service provided hinges on quality control, in-process control guidelines and staff training.

Our Operation Capabilities

Venus Pharmaceutical
Pharmaceutical companies India

Head Office

Panchkula (India)

  • Venus' first manufacturing unit
  • Operation commenced in 1991
  • Intravenous Infusion glass bottle facility
  • Annual manufacturing capacity of 7.5 mn bottles
  • Certifications from Ukraine (PIC nation) WHO-GMP and ISO 9001:2008
  • Therapy focus - Antibiotic Infusions, Neurosurgery Infusion, Pain management
Baddi Pharma

Manufacturing Unit

Baddi (India)

  • Globally - bench marked manufacturing infrastructure
  • 8 manufacturing facilities with annual production capacity of 78.5Mn vials
  • GMP certification from >20 nations
  • Oncology Liquid and Lyophilized : Capacity 25000 vials & 6000 Lyophilized
  • Antibiotics - Cephalosporins, Capacity: 80000 vials
  • Antibiotics - Carbapenems, Capacity: 80000 vials
  • Anticoagulants in Prefilled Syringes: 2,0000 Syringes
  • General Injections: Liquid and Lyophilized: 50000 Vials & Ampoules + 1000 Lyophilized
Facility Approvals
Baddi Pharma
Venus’s Germany office

Subsidiary

Venus Pharma (Germany)

  • Venus commenced its German operations in 2005
  • Wholly-owned subsidiary of Venus
  • Dedicated manufacturing of speciality injectibles
  • Accredited with EU GMP certification
  • Engages in site variation projects, testing , batch release and logistics for Europe
  • World-class quality assurance and quality control laboratories
  • Warehousing capacity of 3,000 pallets under controlled temperature